Stock Scorecard
Stock Summary for Haemonetics Corp (HAE) - $53.74 as of 8/18/2025 10:35:51 AM EST
Total Score
12 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HAE
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HAE
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HAE
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HAE
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HAE (56 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HAE
Financial Details for HAE
Company Overview |
|
|---|---|
| Ticker | HAE |
| Company Name | Haemonetics Corp |
| Country | USA |
| Description | Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/6/2025 |
Stock Price History |
|
| Last Day Price | 53.74 |
| Price 4 Years Ago | 53.04 |
| Last Day Price Updated | 8/18/2025 10:35:51 AM EST |
| Last Day Volume | 1,238,332 |
| Average Daily Volume | 943,783 |
| 52-Week High | 94.98 |
| 52-Week Low | 50.68 |
| Last Price to 52 Week Low | 6.04% |
Valuation Measures |
|
| Trailing PE | 16.00 |
| Industry PE | 40.37 |
| Sector PE | 59.06 |
| 5-Year Average PE | 31.28 |
| Free Cash Flow Ratio | 8.84 |
| Industry Free Cash Flow Ratio | 40.94 |
| Sector Free Cash Flow Ratio | 30.26 |
| Current Ratio Most Recent Quarter | 1.72 |
| Total Cash Per Share | 6.08 |
| Book Value Per Share Most Recent Quarter | 18.32 |
| Price to Book Ratio | 2.94 |
| Industry Price to Book Ratio | 4.88 |
| Sector Price to Book Ratio | 26.93 |
| Price to Sales Ratio Twelve Trailing Months | 1.87 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.13 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.21 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 48,177,300 |
| Market Capitalization | 2,589,048,102 |
| Institutional Ownership | 117.08% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.19% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -5.40% |
| Annual Earnings Growth | 42.64% |
| Reported EPS 12 Trailing Months | 3.27 |
| Reported EPS Past Year | 1.10 |
| Reported EPS Prior Year | 4.12 |
| Net Income Twelve Trailing Months | 163,337,000 |
| Net Income Past Year | 167,679,000 |
| Net Income Prior Year | 117,558,000 |
| Quarterly Revenue Growth YOY | -4.40% |
| 5-Year Revenue Growth | 6.60% |
| Operating Margin Twelve Trailing Months | 20.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 292,898,000 |
| Total Cash Past Year | 306,763,000 |
| Total Cash Prior Year | 178,800,000 |
| Net Cash Position Most Recent Quarter | -627,935,000 |
| Net Cash Position Past Year | -614,467,000 |
| Long Term Debt Past Year | 921,230,000 |
| Long Term Debt Prior Year | 797,564,000 |
| Total Debt Most Recent Quarter | 920,833,000 |
| Equity to Debt Ratio Past Year | 0.47 |
| Equity to Debt Ratio Most Recent Quarter | 0.49 |
| Total Stockholder Equity Past Year | 820,836,000 |
| Total Stockholder Equity Prior Year | 959,959,000 |
| Total Stockholder Equity Most Recent Quarter | 882,300,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 189,165,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.93 |
| Free Cash Flow Past Year | 142,447,000 |
| Free Cash Flow Prior Year | 115,455,000 |
Options |
|
| Put/Call Ratio | 0.10 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -5.10 |
| MACD Signal | -2.40 |
| 20-Day Bollinger Lower Band | 52.87 |
| 20-Day Bollinger Middle Band | 67.17 |
| 20-Day Bollinger Upper Band | 81.47 |
| Beta | 0.40 |
| RSI | 19.41 |
| 50-Day SMA | 71.91 |
| 150-Day SMA | 79.90 |
| 200-Day SMA | 75.23 |
System |
|
| Modified | 8/16/2025 1:14:07 AM EST |